Skip to main content
. 2023 Aug 21;13(8):1226. doi: 10.3390/brainsci13081226

Figure 2.

Figure 2

The role of bioactive compounds and Gut microbiota–brain axis (GMBA) in modulating inflammation associated with diseases. AD: Alzheimer’s disease; FMT: Faecal microbiota transplantation; IBD: Inflammatory bowel disease; IBS: irritable bowel syndrome; CRC: colorectal cancer; GM: gut microbiota; BBB: blood–brain barrier; SCFAs: Short-chain fatty acids; TXNIP: thioredoxin-interacting protein; NF-κB: nuclear factor-kappa B; NLRP3 (NLR Family Pyrin Domain Containing 3). Created with BioRender.com, accessed on 8 August 2023.